Skip to Content

Ceftazidime Pregnancy and Breastfeeding Warnings

Ceftazidime is also known as: Ceptaz, Fortaz, Tazicef, Tazicef Novaplus, Tazidime

Medically reviewed by Last updated on Sep 11, 2017.

Ceftazidime Pregnancy Warnings

One uncontrolled study of pregnant women between 19 and 21 weeks gestation has suggested that ceftazidime serum concentrations are approximately 50% those expected in nonpregnant women.

Ceftazidime has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal any evidence of teratogenicity. There are no controlled data in human pregnancy. Ceftazidime should only be given during pregnancy when need has been clearly established.

See references

Ceftazidime Breastfeeding Warnings

Ceftazidime is excreted into human milk in small amounts. Ceftazidime is considered compatible with breast-feeding by the American Academy of Pediatrics. The manufacturer recommends that caution be used when administering ceftazidime to nursing women.

See references

References for pregnancy information

  1. Giamarellou H, Gazis J, Petrikkos G, et al "A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy." Am J Obstet Gynecol 147 (1983): 914-9
  2. "Product Information. Fortaz (ceftazidime)." Glaxo Wellcome, Research Triangle Park, NC.
  3. Heikkila A, Erkkola R "Review of beta-lactam antibiotics in pregnancy - the need for adjustment of dosage schedules." Clin Pharmacokinet 27 (1994): 49-62
  4. Nathorstboos J, Philipson A, Hedman A, Arvisson A "Renal elimination of ceftazidime during pregnancy." Am J Obstet Gynecol 172 (1995): 163-6

References for breastfeeding information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. Blanco JD, Jorgensen JH, Castaneda YS, Crawford SA "Ceftazidime levels in human breast milk." Antimicrob Agents Chemother 23 (1983): 479-80
  3. "Product Information. Fortaz (ceftazidime)." Glaxo Wellcome, Research Triangle Park, NC.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.